Latest Breaking News On - Gamaleya national research centre - Page 9 : comparemela.com

Russia s Sputnik V Vaccine Gets Emergency Use Authorisation in India; All You Need to Know News18 1 hour ago News18 © Provided by News18 Russia s Sputnik V Vaccine Gets Emergency Use Authorisation in India; All You Need to Know Russian COVID-19 vaccine Sputnik V was on Monday given approval for emergency use authorisation in India by the Subject Expert Committee (SEC), constituted by the central government. The SEC nod came on drugmaker Dr Reddy’s application seeking authorisation for the vaccine in India. Dr Reddy’s has partnered with the Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India. India has been pledged 125 million doses of the vaccine by Russia. India, the world’s largest vaccine maker, has become one of the biggest producers of the Sputnik V shot outside Russia. Other countries producing it include Brazil, China and South Korea. RDIF has also partnered with Indian pharma firms such as Panacea Biotec, Hetero, Gla

South koreaArvinder singh soinDenis logunovStelis biopharmaInstitute of liver transplantationRussia direct investment fundGamaleya national research centre for epidemiologyExpert committeeAll you needSubject expert committeePanacea biotecGland pharmaSerious adverse eventsSputnikv vaccine worksGamaleya national research centreBridging trials